These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27825542)

  • 1. Histopathological tumor invasion of the mesenterico-portal vein is characterized by aggressive biology and stromal fibroblast activation.
    Lapshyn H; Bolm L; Kohler I; Werner M; Billmann FG; Bausch D; Hopt UT; Makowiec F; Wittel UA; Keck T; Bronsert P; Wellner UF
    HPB (Oxford); 2017 Jan; 19(1):67-74. PubMed ID: 27825542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors after pancreatoduodenectomy with en bloc portal venous resection for pancreatic cancer.
    Lapshyn H; Bronsert P; Bolm L; Werner M; Hopt UT; Makowiec F; Wittel UA; Keck T; Wellner UF; Bausch D
    Langenbecks Arch Surg; 2016 Feb; 401(1):63-9. PubMed ID: 26739620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection.
    Riediger H; Makowiec F; Fischer E; Adam U; Hopt UT
    J Gastrointest Surg; 2006; 10(8):1106-15. PubMed ID: 16966029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
    Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
    Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion.
    Wang WL; Ye S; Yan S; Shen Y; Zhang M; Wu J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):429-35. PubMed ID: 26256089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiological prediction of portal vein infiltration in patients with pancreatic ductal adenocarcinoma.
    Lapshyn H; Schulte T; Sondermann S; May K; Petrova E; Honselmann KC; Braun R; Zemskov S; Keck T; Wellner UF; Bausch D; Bolm L
    Pancreatology; 2021 Jan; 21(1):155-162. PubMed ID: 33309623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
    Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
    ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
    Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
    BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
    Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
    Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of cryopreserved homologous veins for venous reconstruction in pancreatoduodenectomy.
    Yamamoto M; Akamatsu N; Aoki T; Sakamoto Y; Tamura S; Hasegawa K; Kokudo N
    Surgery; 2017 Feb; 161(2):385-393. PubMed ID: 27726914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.
    Mierke F; Hempel S; Distler M; Aust DE; Saeger HD; Weitz J; Welsch T
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
    Fuhrman GM; Leach SD; Staley CA; Cusack JC; Charnsangavej C; Cleary KR; El-Naggar AK; Fenoglio CJ; Lee JE; Evans DB
    Ann Surg; 1996 Feb; 223(2):154-62. PubMed ID: 8597509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
    Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
    Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens.
    Delpero JR; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Autret A; Turrini O; Monges-Ranchin G; Boher JM
    HPB (Oxford); 2014 Jan; 16(1):20-33. PubMed ID: 23464850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
    Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
    Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
    Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative Outcomes of Tangential
    Lapshyn H; Schulte T; Petruch N; Petrova E; Honselmann K; Deichmann S; Braun R; Kulemann B; Hoeppner J; Rades D; Keck T; Wellner UF; Bausch D; Bolm L
    Anticancer Res; 2021 Oct; 41(10):5123-5130. PubMed ID: 34593463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of pathological positive superior mesenteric/portal venous invasion in pancreatic cancer.
    Tewari M
    Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):572-578. PubMed ID: 27919845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenterico-portal vein resection in patients with pancreatico-duodenal cancer is safe and may increase survival.
    Storkholm JH; Hansen CP
    Dan Med J; 2014 Jan; 61(1):A4757. PubMed ID: 24393587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.